Mind Medicine (MNMD) Tops Q3 EPS by 20c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• 374Water Inc (SCWO) Misses Q2 EPS by 15c